Steenbrugge, J., Elst, N. V., Demeyere, K., Wever, O. D., Sanders, N. N., Broeck, W. V. D., . . . Meyer, E. (2021). OMO-1 reduces progression and enhances cisplatin efficacy in a 4T1-based non-c-MET addicted intraductal mouse model for triple-negative breast cancer. Nature Portfolio.
Cita Chicago Style (17a ed.)Steenbrugge, Jonas, Niels Vander Elst, Kristel Demeyere, Olivier De Wever, Niek N. Sanders, Wim Van Den Broeck, Eric Ciamporcero, Timothy Perera, y Evelyne Meyer. OMO-1 Reduces Progression and Enhances Cisplatin Efficacy in a 4T1-based Non-c-MET Addicted Intraductal Mouse Model for Triple-negative Breast Cancer. Nature Portfolio, 2021.
Cita MLA (8a ed.)Steenbrugge, Jonas, et al. OMO-1 Reduces Progression and Enhances Cisplatin Efficacy in a 4T1-based Non-c-MET Addicted Intraductal Mouse Model for Triple-negative Breast Cancer. Nature Portfolio, 2021.